Context Therapeutics Inc. (CNTX)

CIK 0001842952 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 —
Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statement of Cash Flows
Consolidated Statements of Changes In Stockholders' Equity (P)
Notes
Accrued Expenses and Other Current Liabilities
Basis of Presentation and Summary of Significant Accounting Policies
Commitment and Contingencies
Commitment and Contingencies, Including License Agreements
—
Cybersecurity Risk Management and Strategy Disclosure
—
Fair Value Measurements
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Organization and Description of Business
Pay Vs Performance Disclosure
Risks and Liquidity
Share-based Compensation
Stockholders' Equity
Subsequent Event